Table 1

Characteristics of the patients with RA. Values represent means unless stated otherwise

CharacteristicsPatients with RA (n=14)
DMARD, disease modifying antirheumatic drug; NSAID, non-steroidal anti-inflammatory drug; DAS28 score, the modified Disease Activity Score,19 using patient global visual analogue scale assessment of current disease activity.20
Age (years), (SD; median)42.4 (5.8; 43.5)
Men/women3/11
Disease duration (years) (SD; median)11.1 (6.3; 13)
RF positive (No (%))10 (71)
Extra-articular RA (n)2
Past joint surgery for RA (No (%))7 (50)
Current DMARD (No (%))13 (93)
    Methotrexate10
    Sulfasalazine4
    Azathioprine2
    Intramuscular gold1
    Cyclosporin1
Current NSAID (No (%))13 (93)
Current prednisolone treatment (No (%))4 (29)
Current prednisolone dose (mg/day) (SD)5.5 (1.4)
Morning joint stiffness (min) (SD; median)62 (56; 53)
28 Tender joint count (n) (SD; median)6 (4.3; 6)
28 Swollen joint count (n) (SD; median)7 (4.9; 6)
ESR (mm/1st h) (SD; median)27 (15; 25)
CRP (mg/l) (SD; median)19 (15; 14)
DAS28 (SD; median)4.60 (1.6; 5.30)